Related Experiment Video
Updated: Feb 14, 2026

Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model
Published on: July 26, 2011
Aβ pathology downregulates brain mGluR5 density in a mouse model of Alzheimer
Minkyung Lee1, Hae-June Lee2, In Suh Park3
1Department of Nuclear Medicine, School of Medicine, Inha University, Incheon, South Korea.
Abstract:
The aim of the present study was to evaluate functional changes of mGluR5 expression in advanced Alzheimer's disease (AD) using positron emission tomography (PET) with an mGluR5 specific radiotracer ([18F]FPEB) in 5xFAD AD model. Subsequently, in the same animal, mGluR5 expression was quantified by immunoassay techniques. The non-displaceable binding potential values for mGluR5 was estimated by the Logan's graphical analysis. Brain PET imaging revealed that radioactivities in the hippocampus and the striatum were significantly lower in 5xFAD mice compared to control animals. Binding values were also significantly lowered in 5xFAD mice. This decline was validated by immunoblotting of protein isolates from brain tissues, as the mean band density for 5xFAD mice had a lower mGluR5 intensity than for wild type mice. These results indicated that mGluR5 levels in 5xFAD mice were down regulated in the limbic system.
Insights
This study found reduced metabotropic glutamate receptor 5 (mGluR5) expression in the brains of advanced Alzheimer's disease (AD) mouse models. Positron emission tomography and immunoassay confirmed lower mGluR5 levels, particularly in the limbic system.
Area of Science:
- Neuroscience
- Molecular Biology
- Medical Imaging
Background:
- Alzheimer's disease (AD) is a progressive neurodegenerative disorder.
- Metabotropic glutamate receptor 5 (mGluR5) plays a role in synaptic plasticity and neuronal function.
- Dysregulation of mGluR5 has been implicated in AD pathogenesis.
Purpose of the Study:
- To investigate functional changes in mGluR5 expression in an advanced AD mouse model (5xFAD).
- To quantify mGluR5 levels using positron emission tomography (PET) and immunoassay techniques.
Main Methods:
- Utilized PET imaging with the mGluR5-specific radiotracer [18F]FPEB in 5xFAD and wild-type mice.
- Quantified non-displaceable binding potential (BPND) using Logan's graphical analysis.
- Validated PET findings through immunoblotting of brain tissue protein isolates.
Main Results:
- PET imaging revealed significantly lower radioactivities in the hippocampus and striatum of 5xFAD mice compared to controls.
- Estimated mGluR5 binding values were significantly reduced in 5xFAD mice.
- Immunoblotting confirmed lower mGluR5 protein intensity in 5xFAD mice brain tissues.
Conclusions:
- mGluR5 levels are significantly down-regulated in the limbic system of the 5xFAD mouse model of Alzheimer's disease.
- These findings suggest a potential role for mGluR5 dysregulation in AD progression.
- PET imaging with [18F]FPEB is a viable method for assessing mGluR5 changes in AD models.
More Related Videos
08:29Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
06:19Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
Published on: October 20, 2023
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Alzheimer's Disease: Treatment
Density
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Current Density
Strain-Energy Density
In the elastic region of a material, the relationship between the stress and the strain is linear and follows Hooke's Law. The strain energy density in this region...